Exploring the nonlinear effects of patent H index, patent citations, and essential technological strength on corporate performance by using artificial neural network

This study utilizes the artificial neural network to explore the nonlinear relationships between patent performance and the corporate performance of the pharmaceutical companies. Patent performance measured from patent H index, patent citations, and essential technological strength (ETS). The result shows that patent H index, patent citations, and ETS has the nonlinear effect on the corporate performance of the pharmaceutical companies.

[1]  Barry A. Wray,et al.  Using Neural Network Analysis to Evaluate Buyer‐Seller Relationships , 1994 .

[2]  Saeed Moshiri,et al.  Neural Network versus Econometric Models in Forecasting Inflation , 1999 .

[3]  Jiancheng Guan,et al.  Exploring the h-index at patent level , 2009 .

[4]  George Cybenko,et al.  Approximation by superpositions of a sigmoidal function , 1992, Math. Control. Signals Syst..

[5]  Toby E. Stuart,et al.  Local search and the evolution of technological capabilities , 2007 .

[6]  Elizabeth J. Jensen.  Research Expenditures and the Discovery of New Drugs , 1987 .

[7]  M. Hitt,et al.  The new competitive landscape , 1995 .

[8]  Kimberly S. Hamilton,et al.  The increasing linkage between U.S. technology and public science , 1997 .

[9]  Raynold A. Svenson,et al.  Measuring R&D Productivity , 1988 .

[10]  Mark S. Klock,et al.  The Relation Between Patent Citations and Tobin's Q in the Semiconductor Industry , 1997 .

[11]  Michael Stolpe,et al.  Determinants of knowledge diffusion as evidenced in patent data: the case of liquid crystal display technology , 2002 .

[12]  Philip D. Wasserman,et al.  Advanced methods in neural computing , 1993, VNR computer library.

[13]  H. White.  Some Asymptotic Results for Learning in Single Hidden-Layer Feedforward Network Models , 1989 .

[14]  Vasanthakumar N. Bhat,et al.  Patent term extension strategies in the pharmaceutical industry , 2005 .

[15]  Yu-Shan Chen,et al.  The nonlinear nature of the relationships between the patent traits and corporate performance , 2009, Scientometrics.

[16]  Mu-Hsuan Huang,et al.  The relationships between the patent performance and corporation performance , 2012, J. Informetrics.

[17]  J. E. Hirsch,et al.  An index to quantify an individual's scientific research output , 2005, Proc. Natl. Acad. Sci. USA.

[18]  Kurt Hornik,et al.  Multilayer feedforward networks are universal approximators , 1989, Neural Networks.

[19]  K. P. Sudheer,et al.  A neuro-fuzzy computing technique for modeling hydrological time series , 2004 .

[20]  Laura B. Cardinal,et al.  Internal knowledge generation: the research laboratory and innovative productivity in the pharmaceutical industry , 2000 .

[21]  Manuel Trajtenberg,et al.  Market Value and Patent Citations: A First Look , 2000 .

[22]  Geoffrey E. Hinton,et al.  Learning representations by back-propagating errors , 1986, Nature.

[23]  Henry G. Grabowski,et al.  A New Look at the Returns and Risks to Pharmaceutical R&D , 1990 .

[24]  A. J. Morris,et al.  Artificial neural networks and multivariate statistics , 2000 .

[25]  F. Scherer,et al.  Patent Statistics as a Measure of Technical Change , 1969, Journal of Political Economy.

[26]  Bronwyn H Hall,et al.  Market value and patent citations , 2005 .

[27]  M. Trajtenberg.  A Penny for Your Quotes : Patent Citations and the Value of Innovations , 1990 .

[28]  Mohammed Wanous,et al.  A neural network bid/no bid model: the case for contractors in Syria , 2003 .

[29]  R. Lippmann,et al.  An introduction to computing with neural nets , 1987, IEEE ASSP Magazine.

[30]  Yu-Shan Chen,et al.  Analyzing the nonlinear effects of firm size, profitability, and employee productivity on patent citations of the US pharmaceutical companies by using artificial neural network , 2009, Scientometrics.

[31]  R. Shortridge,et al.  Market Valuation of Successful Versus Non-Successful R&D Efforts in the Pharmaceutical Industry , 2004 .

[32]  Yu-Shan Chen,et al.  Exploring the nonlinear effects of patent citations, patent share and relative patent position on market value in the US pharmaceutical industry , 2010, Technol. Anal. Strateg. Manag..

[33]  Yu-Shan Chen,et al.  The relationship between a firm's patent quality and its market value — The case of US pharmaceutical industry , 2010 .

[34]  Mark A. Schankerman,et al.  Patent Quality and Research Productivity: Measuring Innovation with Multiple Indicators , 2004 .

[35]  Mu-Hsuan Huang,et al.  Using Essential Patent Index and Essential Technological Strength to evaluate industrial technological innovation competitiveness , 2007, Scientometrics.

[36]  F. Narin,et al.  Patents as indicators of corporate technological strength , 1987 .

[37]  Z. Griliches.  Patent Statistics as Economic Indicators: a Survey , 1990 .

[38]  E. Mansfield.  Patents and Innovation: An Empirical Study , 1986 .

[39]  Yu-Shan Chen,et al.  Using neural network to analyze the influence of the patent performance upon the market value of the US pharmaceutical companies , 2009, Scientometrics.

[40]  Brant C. White,et al.  United States patent , 1985 .